Expression of full-length FOXP3 exceeds other isoforms in thymus and stimulated CD4+ T cells
Standard
Expression of full-length FOXP3 exceeds other isoforms in thymus and stimulated CD4+ T cells. / Kröger, Benita; Spohn, Michael; Mengel, Marion; Sperhake, Jan-Peter; Ondruschka, Benjamin; Mailer, Reiner.
in: J CLIN IMMUNOL, Jahrgang 44, Nr. 5, 27.04.2024, S. 114.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Kommentar › Forschung
Harvard
Kröger, B, Spohn, M, Mengel, M, Sperhake, J-P, Ondruschka, B & Mailer, R 2024, 'Expression of full-length FOXP3 exceeds other isoforms in thymus and stimulated CD4+ T cells', J CLIN IMMUNOL, Jg. 44, Nr. 5, S. 114. https://doi.org/10.1007/s10875-024-01715-8
APA
Kröger, B., Spohn, M., Mengel, M., Sperhake, J-P., Ondruschka, B., & Mailer, R. (2024). Expression of full-length FOXP3 exceeds other isoforms in thymus and stimulated CD4+ T cells. J CLIN IMMUNOL, 44(5), 114. https://doi.org/10.1007/s10875-024-01715-8
Vancouver
Kröger B, Spohn M, Mengel M, Sperhake J-P, Ondruschka B, Mailer R. Expression of full-length FOXP3 exceeds other isoforms in thymus and stimulated CD4+ T cells. J CLIN IMMUNOL. 2024 Apr 27;44(5):114. https://doi.org/10.1007/s10875-024-01715-8
Bibtex
@article{fa222d67050141f982d8b6b3e1061642,
title = "Expression of full-length FOXP3 exceeds other isoforms in thymus and stimulated CD4+ T cells",
author = "Benita Kr{\"o}ger and Michael Spohn and Marion Mengel and Jan-Peter Sperhake and Benjamin Ondruschka and Reiner Mailer",
year = "2024",
month = apr,
day = "27",
doi = "10.1007/s10875-024-01715-8",
language = "English",
volume = "44",
pages = "114",
journal = "J CLIN IMMUNOL",
issn = "0271-9142",
publisher = "Springer New York",
number = "5",
}
RIS
TY - JOUR
T1 - Expression of full-length FOXP3 exceeds other isoforms in thymus and stimulated CD4+ T cells
AU - Kröger, Benita
AU - Spohn, Michael
AU - Mengel, Marion
AU - Sperhake, Jan-Peter
AU - Ondruschka, Benjamin
AU - Mailer, Reiner
PY - 2024/4/27
Y1 - 2024/4/27
U2 - 10.1007/s10875-024-01715-8
DO - 10.1007/s10875-024-01715-8
M3 - Comment/debate
C2 - 38676826
VL - 44
SP - 114
JO - J CLIN IMMUNOL
JF - J CLIN IMMUNOL
SN - 0271-9142
IS - 5
ER -
